VTE prophylaxis

Assess every medical inpatient for VTE risk on admission, reassess at 24 h or on any change. Weigh thrombosis vs bleeding risk, then choose pharmacological, mechanical, or both.

Risk score: Padua (medical inpatients)

Risk factorPoints
Active cancer3
Previous VTE (excluding superficial)3
Reduced mobility (bedrest ≥ 3 days)3
Known thrombophilia3
Recent (≤ 1 month) trauma or surgery2
Age ≥ 701
Heart and/or respiratory failure1
Acute MI or ischaemic stroke1
Acute infection or rheumatological disorder1
BMI ≥ 301
Ongoing hormonal treatment1

Score ≥ 4 = high risk → pharmacological prophylaxis if no bleeding contraindication · Padua score · MDCalc ↗︎

When to avoid pharmacological prophylaxis (bleeding risk)

Contraindication / caution
Active bleeding
Platelets < 50
Acute haemorrhagic stroke
Severe uncontrolled hypertension
Known bleeding disorder or on therapeutic anticoagulation
Recent neurosurgery / spinal surgery, or LP within 4 h

If pharmacological prophylaxis is contraindicated, use mechanical prophylaxis and reassess daily.

Options

TypeAgent / deviceDose / use
LMWHEnoxaparin (Clexane)40 mg SC OD; weight < 50 kg or BMI > 40 → adjust per local policy
UFH, if CrCl < 30Heparin5,000 units SC q8–12h (or enoxaparin 20 mg SC OD per local policy)
MechanicalPneumatic compression (IPC) or anti-embolism stockingsWhen anticoagulation is contraindicated; no stockings in significant PAD

Educational reference for clinicians. Padua thresholds, prophylaxis choices, contraindications, and renal function must be checked against current local policy before use.

Last updated · October 2026